-->

Tech Seeker (TS)

Abcam plc
Profile last edited on: 4/7/2022

Identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery
TS Type
Mid-size Corporation
Status
Active
Year Founded
1998
Last Involved Year
2015

Key People / Management

  Alan Thomas Hirzel -- CEO & Exec. Director

  Michael Shaun Baldock -- CFO & Director

Location Information

Discovery Drive Cambridge Biomedical Campus
Cambridge, GB CB2 0AX
   (441) 223-696000
   www.abcam.com

Public Profile

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
UK
Employment
1,650
Revenue
$0.3B
Public/Private
Publicly Traded
Stock Info
NASDAQ : ABCM
Received SBIR $$
No